Angela Oh Selected Research

p21-Activated Kinases

12/2015

Design of Selective PAK1 Inhibitor G-5555: Improving Properties by Employing an Unorthodox Low-pK a Polar Moiety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela Oh Research Topics

Disease

7	Neoplasms (Cancer) 01/2016 - 04/2013
1	Carcinogenesis 12/2015
1	Triple Negative Breast Neoplasms 02/2014
1	Sarcoma (Soft Tissue Sarcoma) 04/2013
1	Inflammation (Inflammations) 04/2013
1	Obesity 01/2009
1	Body Weight (Weight, Body) 01/2009

Drug/Important Bio-Agent (IBA)

1	Phosphotransferases (Kinase)IBA 01/2016
1	p21-Activated KinasesIBA 12/2015
1	Nicotinamide PhosphoribosyltransferaseIBA 05/2014
1	compound 17IBA 02/2014
1	NAD (NADH)IBA 01/2014
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2014
1	TransferasesIBA 01/2014
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 10/2013
1	Pharmaceutical PreparationsIBA 04/2013
1	Cell Surface ReceptorsIBA 04/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2009
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	AdiponectinIBA 01/2009
1	CholesterolIBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2014 - 04/2013